The 3rd Transparency & Aggregate Spend Summit, held on June 3-4, 2024, in Philadelphia, focused on the latest challenges and solutions in HCP spend reporting compliance for the life sciences industry. Attendees delved into new state requirements, global transparency, and data analytics, with special attention to CMS audits. The speaking faculty included colleagues from Johnson & Johnson, Roche Diagnostics, and Takeda.

The event featured interactive breakout groups and expert-led sessions, fostering deep discussions on improving data capture and compliance processes. Key topics included strategies for managing state reporting requirements and leveraging data analytics for compliance efficiency. The summit provided a platform for professionals from pharmaceutical, biotech, and medical device sectors to share experiences and best practices, promoting a comprehensive understanding of transparency reporting requirements.

For those unable to attend in person, an On-Demand option is available, allowing participants to access all the conference content from anywhere at any time. This ensures broader accessibility to the valuable insights and discussions from the event.

Learn more today: https://dgevents.com/event/transparency-aggregate-spend-summit/

• The demand for gold continues to increase while new resource supply remains scarce, creating the potential for a supply chain imbalance in the future
• Emperor Metals is a Canada-headquartered explorer, working to develop a storied resource in southwest Quebec that contains an estimated mineral resource of 727,000 ounces of gold identified at a grade of 5.42 g/t Au
• The company’s flagship project exhibited new possibilities in 2023 when Emperor discovered the potential for a large-scale open pit above a high-grade underground gold deposit
• Emperor followed on last year’s landmark development with an 8,000-meter drill program into the deposit launched last month along with an 8,000-meter core sampling project in the open pit

A demand-supply imbalance appears to be developing in the gold market as the precious metal sees increasing use in the energy, healthcare, and technology sectors, and its growing safe-haven investment status, results in a continuing increase in demand from central banks despite a scarcity of gold deposits entering the market.

“The bigger picture, I think about mine production is that, effectively, it plateaued around 2016, 2018 and we’ve seen no growth since then,” World Gold Council (“WGC”) Chief Market Strategist John Reade stated in a Zacks report on the market (https://ibn.fm/tmOKh).

Advanced stage gold explorer Emperor Metals (CSE: AUOZ) (OTCQB: EMAUF) (FRA: 9NH) is envisioning a potential new source in southwest Quebec, where it is developing its flagship Duquesne West Gold Project.

Emperor is working to update and prove the historical mineral resource estimate at its flagship project covering 1,389 hectares (3,432 acres) to comply with modern standards by the first quarter of next year. The site’s 38 claims host a historical inferred mineral resource estimate of 727,000 ounces of gold in 4.17 million tonnes of material grading 5.42 g/t gold.

The company launched an 8,000-meter drilling program with 8,000 meters of core sampling for historical assaying last month. A discovery last year pointed to the potential that a large-scale open pit exists above a high-grade underground gold deposit. The discovery had originally captured Emperor’s interests and drove a redirection of the exploration program, with “70 to 80 percent” of the drilling looking at the open pit potential this year, according to Emperor Metals President and CEO John Florek (https://ibn.fm/VZUfO).

“(The open pit boundary) is really kind of still open to the east and to the west. But we also want to drill some of that underground stuff because right below the open pit is those underground, high-grade ounces,” he said. “This gives Emperor the ability to add ounces more rapidly on this project due to the capability of adding potentially open pitable mineralization above the high-grade historical resource,” Florek added in a company news release last month (https://ibn.fm/dLQgN). “Emperor is well funded with approximately $4 million in working capital.”

McEwen Mining Inc. CEO Robert McEwen, the founder of Goldcorp, invested $1 million for 8 percent of the company during a recent private placement financing round, a sign of optimism for Emperor’s potential. “He sees the opportunity for this district,” Florek said during a May Mining Book interview (https://ibn.fm/akExK). “He sees the growth potential that we’re showing, and the value and the success that we’re having from using AI (to create 3D modeling).”

Public documents show exploration at the Duquesne West property began around 1927 and various companies have undertaken the complicated task of gold exploration during the years since (https://ibn.fm/XSFZi).

The project has a year-round maintained road near a highway that connects it to an international airport, and also has access to a local power supply. It lies within the historic Duparquet gold mining camp in the southern portion of the Abitibi Greenstone Belt.

For more information, visit the company’s website at www.EmperorMetals.com.

NOTE TO INVESTORS: The latest news and updates relating to EMAUF are available in the company’s newsroom at https://ibn.fm/EMAUF

• “A myriad of opportunities has emerged for (cannabis) investors, entrepreneurs and enthusiasts worldwide,” reports Newsweek
• MedCana’s agreement to begin exporting CBD buds to Switzerland appears to be particularly timely
• The company noted that this new collaboration marks a “significant milestone” in the company’s expansion into the European market

Interest in cannabis is growing globally, and savvy companies operating in the cannabis space, such as Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ), are working to strengthen their positions. Most recently, MedCana announced a new strategic partnership between one of its subsidiaries and a prominent Colombian company to begin export of its first crop of CBD buds to Switzerland within the next six months (https://cnw.fm/CeJOk).

“Since U.S. states such as Colorado initiated the legalization and regulation of recreational cannabis a decade ago, there has been a simultaneous shift in attitudes toward cannabis prohibition in countries around the world,” a recent Newsweek article reported (https://cnw.fm/NJUG4). “As more countries recognize the potential benefits of cannabis, both medically and recreationally, a myriad of opportunities has emerged for investors, entrepreneurs and enthusiasts worldwide.

“Today, the cannabis market worldwide is projected to reach nearly $61 billion in revenue in 2024 and is expected to reach $103 billion by 2028,” the article continued. “With almost 448.4 million people, the European Union has a potential cannabis market larger than the United States and Canada combined. At present, some form of medicinal cannabis is legal in 23 European countries, including Germany, the Netherlands and Italy, and five nations have decriminalized it. Several other European nations are embracing cannabis legalization to varying degrees, while some countries, such as Portugal and Luxembourg, are exploring or have implemented full recreational legalization.”

With these projections, MedCana’s agreement to begin exporting CBD buds to Switzerland appears to be particularly timely. A holding company focused on the cannabis and agricultural technology sectors, MedCana noted that this new collaboration marks a “significant milestone” in the company’s expansion into the European market and its commitment to delivering high-quality CBD products internationally.

“We are thrilled to partner with such a reputable local company in Colombia,” said MedCana CEO Gabriel Diaz. “This partnership not only strengthens our supply chain but also underscores our dedication to bringing premium CBD products to the global market. Switzerland represents a key market for us, and we are excited about the potential growth this collaboration will bring.”

Although the Colombian partner remains unnamed, the entity is known for its excellence in cultivation and processes, and the collaboration is designed to leverage the strengths of both companies to ensure the successful export of CBD buds that meet the high-quality standards of the Swiss market. This strategic move aligns with MedCana’s strategic goals of expanding its footprint in Europe and promoting sustainable agricultural practices in Colombia.

“This collaboration with MedCana is a testament to our shared vision of producing and delivering the highest-quality CBD products,” said Diego Flores, executive director of the Colombian partner. “We are eager to begin this journey and look forward to a prosperous partnership.”

MedCana is committed to advancing cannabis production and agricultural technology around the world, while also driving innovation and promoting sustainability. As the company moves forward with its strategic growth plans, stakeholders can expect to see enhanced profitability and a stronger global presence.

Software Effective Solutions/MedCana is a holding company focused on developing companies in the agricultural technology and cannabis industries. The company remains dedicated to delivering on its promise of building a solid foundation for future growth of its holdings.

For more information, visit the company’s website at www.MedCana.net.

NOTE TO INVESTORS: The latest news and updates relating to SFWJ are available in the company’s newsroom at https://cnw.fm/SFWJ

• GTVH enters pivotal agreement with largest note holder, T&K Zarro LLC
• CEO notes that agreement demonstrates “our commitment to strengthening our capital structure and delivering tangible value to our shareholders”
• The agreement is a “testament” to the company’s strategic foresight and dedication to fostering a robust and scalable business model

Golden Triangle Ventures (OTC: GTVH) continues momentum as the company announces strategic steps in its commitment to solidifying its capital structure, expanding its business operations and enhancing shareholder value. Most recently, the company revealed a pivotal agreement with T&K Zarro LLC, GTVH’s largest note holder (https://ibn.fm/B79wk).

“This agreement marks a transformative moment for Golden Triangle Ventures,” said GTVH president Steffan Dalsgaard. “By aligning our interests with T&K Zarro, we are demonstrating our commitment to strengthening our capital structure and delivering tangible value to our shareholders. We are confident that these measures will elevate GTVH to new heights and strengthen our position in the public markets.”

Calling the transaction a “landmark agreement,” Golden Triangle Ventures noted that T&K Zarro has committed to a structured and disciplined sale of GTVH stock, limiting sales to no more than 10% of the daily trading volume on any given day. In addition, the agreement notes that T&K Zarro has agreed to a six-month moratorium on all interest accruals within its convertible debentures held in Golden Triangle.

“This moratorium period is designed to provide GTVH with the necessary time to optimize its operations and capitalize on growth opportunities,” the company noted in the announcement. “This initiative underscores GTVH’s dedication to continuously enhancing shareholder value as the company scales its operations.”

The agreement is “a testament to Golden Triangle Ventures’ strategic foresight and dedication to fostering a robust and scalable business model,” the company continued. According to the announcement, GTVH is focused on reinforcing shareholders’ investment in the company by expanding operations and optimizing capital structure, ultimately creating significant and sustainable growth.

Tom Zarro, president of T&K Zarro, noted that he is fully committed to the long-term success of Golden Triangle Ventures. “This agreement reflects my confidence in the company’s leadership and its vision for growth,” stated Zarro. “By placing a temporary moratorium on interest and adhering to a disciplined approach to stock sales, we are setting the stage for sustainable growth and enhanced shareholder value. I look forward to supporting GTVH as it embarks on this exciting journey.”

A multifaceted consulting company, Golden Triangle Ventures operates as a parent business pursuing ventures in the health, entertainment and technology sectors. The company is looking  to purchase, acquire and/or joint venture with established entities within these areas of business. The goods and services represented are driven by innovators who have passion and commitment in these marketplaces. The company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services. The three points of the Golden Triangle exclusively represent the three sectors the company aims to do business in.

For more information, visit the company’s website at www.GoldenTriangleInc.com.

NOTE TO INVESTORS: The latest news and updates relating to GTVH are available in the company’s newsroom at https://ibn.fm/GTVH

• Energy and Water Development, a green-tech engineering solutions company focused on delivering water and energy to extreme environments, is looking to make clean water accessible with its patent-pending, innovative solution
• The company’s Atmosphere Water Generation (“AWD”) uses ultra-efficient refrigeration technology for condensation of air, providing an unlimited water resource directly from the atmosphere
• With multiple coordinated units, the technology can produce up to 2.6 million gallons of water a day for industrial, residential, and commercial use
• EAWD’s management is confident that, through this innovative solution, it could provide millions of liters of fresh, clean water every day while preventing the depletion of water from natural resources

Energy and Water Development (OTCQB: EAWD), a green-tech engineering solutions company focused on delivering water and energy to extreme environments, has, since its inception, remained committed to providing sustainable energy and water solutions to residential, industrial, and commercial markets. Its focus has been on regions with scarce water and energy supply. Sadly, with ongoing climate change, the situation is only worsening, but the company is looking to address it through its AWD technology.

It is estimated that close to 2.4 billion people in the world today live in water-scarce areas. At least 703 million people, which translates to almost one in 10 people, currently do not have clean water close to home (https://ibn.fm/TnDXu). Worse still, for many who do not have access, the service may be unreliable, unsafe, unaffordable, or far away. Despite the Sustainable Development Goal (“SDG”) that details the objective to make clean water accessible to as many people as possible, it is still projected that by 2030, at least 2 billion people will still not have access to safe water at home, a worrying statistic that also lays bare the current state of the situation on the ground (https://ibn.fm/oZnJ6).

Through its patent-pending, innovative off-grid atmosphere water generation (“AWD”) systems, the company is looking to address it at the source. The technology leverages ultra-efficient refrigeration technology for air condensation, allowing for a system that is totally independent of groundwater resources and provides an unlimited water resource. From an environmental standpoint, the solution has no adverse effects on the environment and is totally independent of the grid, which means even people in the most remote locations of the planet can still access clean water.

“We know that water scarcity is a critical and growing issue that does not discriminate,” noted Irma Velazquez, EAWD’s CEO. “Everyone, anywhere, is entitled to clean, abundant drinking water and our improved off-grid atmosphere water generation systems can help communities provide an unlimited source of fresh water without drawing any power from the grid, even in the most severely drought-stricken areas,” he added (https://ibn.fm/x1KJQ).

The company’s focus has been in North America, specifically the U.S. and Mexico. In December 2023, it announced a joint Memorandum of Understanding (“MOU”) to build North America’s first off-grid atmosphere water generation plant. Other community-scale water generation projects are also under development in Mexico and Germany, locations where multiple solar-powered AWGs could produce as much as 2.6 million gallons of water per day for industrial, residential, and commercial use.

EAWD’s management is confident that the company’s innovative solution can provide life-changing volumes of fresh, clean water every day, in areas where it is desperately needed, while preventing the depletion of natural rivers and lakes.

For more information, visit the company’s website at www.Energy-Water.com.

NOTE TO INVESTORS: The latest news and updates relating to EAWD are available in the company’s newsroom at http://ibn.fm/EAWD

• Clene presented findings on HEALEY ALS at the European Network for the Cure of ALS (ENCALS) meeting held in Stockholm, Sweden
• The presentation, titled “Long-Term CNM-Au8(R) Treatment Reduces Neurofilament Light Levels and Improves Survival: Results from the HEALEY ALS Platform Trial,” showcased survival follow-up data
• CNM-Au8 was found to be safe and well-tolerated during the OLE

Clene (NASDAQ: CLNN), through its wholly owned subsidiary, Clene Nanomedicine Inc., is a clinical-stage biopharmaceutical company dedicated to enhancing mitochondrial health and safeguarding neuronal function to combat neurodegenerative diseases such as amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”). This week, Clene unveiled new and important long-term findings regarding CNM-Au8 treatment’s impact on survival rates and neurofilament light (“NfL”) levels from the HEALEY-ALS Platform Trial open label extension (“OLE”) at the European Network for the Cure of ALS (ENCALS) meeting held in Stockholm, Sweden (https://ibn.fm/xGfss).

The presentation, titled “Long-Term CNM-Au8 Treatment Reduces Neurofilament Light Levels and Improves Survival: Results from the HEALEY ALS Platform Trial,” showcased survival follow-up data extending up to 42 months (3.5 years) and long-term NfL biomarker results over 76 weeks. Analyses included identification of a subset of NfL-responders from the HEALEY ALS Platform Trial. The survival analysis encompassed all participants treated with CNM-Au8 30 mg, including those initially given a placebo who later transitioned to CNM-Au8 in the OLE, provided they had complete baseline co-variates.

The survival analysis included participants originally randomized to receive CNM-Au8 30 mg (n=59) and those who transitioned from placebo to CNM-Au8 (n=11). These groups were compared to matched controls from the PRO-ACT clinical trial database over a follow-up period of up to 3.5 years post-baseline.

• CNM-Au8 30 mg treated patients exhibited approximately a 60% reduction in the risk of death compared to matched PRO-ACT controls over the 3.5-year follow-up period
• The covariate-adjusted hazard ratio was 0.431 (95% CI: 0.276-0.672), with a p-value of 0.0002

A subset analysis identified NfL responders: participants showing consistent NfL declines (n=55). Responders were defined as those having all post-baseline measures with either an NfL decrease or repeated declines of at least 10 pg/mL following the commencement of CNM-Au8 treatment.

• Responders demonstrated an average NfL reduction of 28%, suggesting a therapeutic protection against continued axonal loss
• The geometric mean ratio (“GMR”) at Week 76 compared to baseline was 0.72 (95% CI: 0.67 – 0.79), with a p-value of less than 0.0001

These NfL results stem from previously announced analyses of plasma NfL collected from participants (n=99) in the HEALEY OLE who received CNM-Au8 30 mg up to week 76, compared to those initially on placebo for 24 weeks before switching to active treatment for up to 52 weeks. The analysis of long-term treatment with CNM-Au8 30 mg to week 76 demonstrated that CNM-Au8 continued to significantly reduce plasma NfL levels. The GMR versus placebo at week 76 was 0.841 (95% CI: 0.73 – 0.98), with a p-value of 0.023.

Furthermore, CNM-Au8 was found to be safe and well-tolerated during the OLE.

“The clinical evidence of plasma neurofilament reduction, as well as the long-term improved survival results up to 3.5 years compared to an established multi-study ALS dataset of more than 12,000 patients across multiple clinical centers provides further evidence to strongly support CNM-Au8 as a potential treatment for ALS,” said Dr. Benjamin Greenberg, Head of Medical at Clene.

The full poster is available for viewing in the Scientific Posters & Presentations section of the Clene website https://ibn.fm/njSux).

For more information, visit the company’s website at www.Clene.com.

NOTE TO INVESTORS: The latest news and updates relating to CLNN are available in the company’s newsroom at https://ibn.fm/CLNN

• HealthLynked, a leading provider of healthcare technology solutions, recently launched its new online medical record request form, integrated with DocuSign
• The new feature allows patients to seamlessly and securely request their medical records from doctors’ offices, hospitals, and laboratories with just a few clicks
• Through the feature, HealthLynked aims to solve inefficiencies and security issues affecting the flow of health information, helping patients share their medical records with their doctors directly
• The HIPAA, through the Privacy Rule, aims to allow the flow of health information that can help health care providers to provide high-quality health care and to protect the public’s health and well-being

The Standards for Privacy of Individually Identifiable Health Information (“Privacy Rule”), issued by the U.S. Department of Health and Human Services (“HHS”) to implement the requirement of the Health Insurance Portability and Accountability Act (“HIPAA”) of 1996, aims to, among others, allow the “flow of health information needed to provide and promote high-quality health care and to protect the public’s health and well-being.” It permits crucial uses of health information while protecting the privacy of patients (https://ibn.fm/S9hpp).

However, a 2018 Yale study found that American hospitals complicate the process by which patients access medical records. The study reported that many top hospitals in the country “are making it unduly confusing or expensive for patients to gain access to their own medical records.” This is despite the fact that HIPAA and supporting rules guarantee patients access to their protected information in a timely fashion and in the format the patient wants.

“There were overwhelming inconsistencies in information relayed to patients regarding the personal health information they are allowed to request, as well as the formats and costs of release, both within institutions and across institutions,” YaleNews quoted Carolyn Lye, the first author on the study, as saying (https://ibn.fm/bVpok).

The inconsistencies, inefficiencies, and delays in the record sharing process has been sighted by many as one of the main problems within the healthcare system.  As a result, HealthLynked (OTCQB: HLYK), a leading provider of healthcare technology solutions, has developed, as part of its comprehensive healthcare network, a medical record storage facility designed to solve inefficiencies and data security issues. The company recently launched its new online medical record request form, integrated with DocuSign. This cutting-edge feature is part of the company’s HealthLynked Network. It allows patients to seamlessly request their medical records from doctors’ offices, hospitals, and laboratories with just a few clicks (https://ibn.fm/oBDl2).

Once transmitted, the requested records are automatically uploaded to the patients’ respective HealthLynked Network profiles, allowing patients to easily access their own records virtually as well as quickly and easily share them with health care providers when needed. In this regard, the addition of the records to the patients’ profiles creates a centralized, easily accessible, manageable, and shareable repository of individual and collective health data. According to the company, users of the free package can store up to five records, while paid members enjoy unlimited record storage.

“The development of the online medical record request form is a testament to our commitment to leveraging the latest technology to improve patient care. By digitizing and streamlining the process of obtaining medical records, we are making it more user-friendly and compliant with healthcare regulations. Access to more medical records that patients can share with their doctors directly leads to better, more informed patient care,” said Chris Hall, CTO of HealthLynked.

HealthLynked reports that the integration with DocuSign, a pioneer in electronic signature technology, ensures that all requests are secure and encrypted, safeguarding patient confidentiality. The integration also promotes convenience by providing an easy-to-use method of confirming patients’ identities.

“We are thrilled to offer this new feature to our users. By integrating with DocuSign, we are not only enhancing the efficiency and security of medical record requests but also ensuring compliance with digital health standards. This makes it easier for patients to manage their health information, ultimately leading to better patient care through more comprehensive access to medical records,” conveyed Dr. Michael Dent, CEO of HealthLynked.

The HealthLynked Network is a patient-centric medical network that allows users to store their medical information, receive assistance with medical forms and questions, book appointments with any doctor, access telemedicine services anywhere in the country, chat with a nurse, obtain copies of lab results, co-manage family members’ healthcare, and much more.

For more information, visit the company’s website at www.HealthLynked.com.

NOTE TO INVESTORS: The latest news and updates relating to HLYK are available in the company’s newsroom at https://ibn.fm/HLYK

• PayPal reported a 9.4% increase in top-line revenue and a 14% year-over-year growth in total payment volume, highlighting its robust growth trajectory
• The company’s strategic initiatives, including the expansion of Venmo and the introduction of new features like Fastlane, are poised to drive further growth and user engagement
• Despite competition from Apple, PayPal maintains a dominant market share in online payments, with strategic focuses that underscore its competitive edge and resilience

PayPal Holdings (NASDAQ: PYPL), a leading digital payments platform, has been navigating through a period of strong growth amidst a challenging macroeconomic landscape. With a vast user base and a reputation for innovation in the fintech sector, PayPal has established itself as a key player in the digital payments space, competing directly with giants like Apple (NASDAQ: AAPL). Despite facing stiff competition, particularly with Apple’s introduction of new fintech features, PayPal’s recent financial performance and strategic initiatives indicate a robust growth trajectory.

In the first quarter, PayPal reported a notable 9.4% increase in top-line revenue, reaching $7.7 billion, and a 14% year-over-year growth in total payment volume, which hit $404 billion. These figures underscore the company’s ability to expand its operations and attract more transactions across its platform, even in a tough economic environment. The growth in payment transactions per active account, which rose by 13% year-over-year, further demonstrates PayPal’s success in engaging its user base and enhancing transaction frequency.

PayPal’s strategic focus on expanding its services is evident in the growth of its Venmo service, which now boasts 60 million active monthly users in the U.S. The introduction of new features, such as the guest checkout system Fastlane, is expected to drive payment volume and attract first-time users. The emphasis on increasing debit card adoption, which generates nearly 20% more revenue per user than non-debit card users, is a testament to PayPal’s commitment to monetizing its user base effectively. These efforts, coupled with a favorable market valuation with a forward price-to-earnings ratio of 14 times, position PayPal for sustained growth.

Despite the competitive pressures from Apple’s fintech initiatives, PayPal’s dominant market share in online payments, standing at 56% compared to Apple’s 12.6%, suggests resilience in the face of potential market share erosion. The company’s comprehensive suite of payment solutions and its strategic focus on user engagement and monetization through services like Venmo and Fastlane underscore its competitive edge. Moreover, the recent “buy” rating from New Street Research, based on the potential for increased payment volume and improved profit margins, highlights the confidence in PayPal’s growth prospects and its ability to navigate competitive challenges.

Currently trading at $59.78, PayPal’s stock has experienced fluctuations within a narrow range, reflecting the market’s mixed sentiment towards the company’s future amidst increased competition and macroeconomic uncertainties. With a market capitalization of about $62.53 billion and a trading volume of 4,905,062 shares on the NASDAQ exchange, PayPal remains a significant player in the digital payments industry. Despite the short- to medium-term challenges, the company’s strong fundamentals, strategic growth initiatives, and solid financial performance suggest that PayPal’s shares could offer strong returns over the long term, making it a stock to watch in the evolving fintech landscape.

For more information, visit the company’s website at www.PayPal.com.

ROTH is excited to invite companies, entrepreneurs, industries, and businesses to attend the 10th Annual ROTH London Conference, taking place from June 25-27, 2024, at the Four Seasons Hotel London at Park Lane. This event is a premier gathering for small-cap companies, providing significant growth and networking opportunities.

The conference will feature 1-to-1 meetings lasting 40 minutes each, allowing investors and companies to engage in-depth on various sectors, including sustainability, agtech, E&P, metals and mining, and technology. These intimate group meetings are designed to facilitate detailed discussions and valuable connections.

In addition to these meetings, the conference will include presentations from key figures such as Michael Darda, Chief Economist and Market Strategist, and JC O’Hara, Chief Technical Strategist at ROTH. Their presentation on Market Strategy and Overview will be held on June 26, 2024.

This event has a strong reputation, with past conferences drawing hundreds of participants, including institutional investors, family offices, high-net-worth individuals, and equity analysts. Notable attendees include seasoned investors, shareholders, and leading management teams from various industries across Europe.

For startups and new businesses, the conference offers a unique platform to explore opportunities within the global investment community. Attendees will benefit from the insights and strategies shared by experts and have the chance to network with influential figures from multiple sectors.

For more information and to register for the conference, visit the ROTH website.

Companies interested in scheduling one-on-one meetings can contact their ROTH representative directly​.

CannaCon Midwest St. Paul invites like-minded entrepreneurs, investors, public officials, patients, and enthusiasts of the cannabis spectrum, to attend the CannaCon Midwest St. Paul conference August 16-17, 2024. This event is a one-stop solution for the cannabis community looking for resources, education, and collaboration opportunities, for all things cannabis.

The CannaCon conference offers a phenomenal platform for enthusiasts, creatives, growers, and traders in and around the venue, to stay updated with the latest industry trends and develop the best networking connections. They will find the latest cultivation techniques, genetics, supplies, unique industry innovations, business, financial, and legal advice, marketing, branding and more, all under one roof.

World-class leaders and veterans of the cannabis trade will grace the event with their presence. Exhibitors will set up booths at the expo showcasing their latest offerings and innovative ideas. Investors looking for new investment opportunities will find a plethora of potential leads on the exhibitor floor. The event offers one-to-one meetings among entrepreneurs, executives, and investors for an in-depth understanding of the goals and vision of both parties.

Apart from the expo, the event will showcase speaker sessions and panel discussions featuring Former Governor and pro wrestler Jesse Ventura. He will interact with the audience, answer their queries, and offer insightful tips. CannaCon is a global networking forum where cannabis businesses and investors connect to discover new talent and develop long-term collaborations. This event promises greater trade and opportunities for cannabis industries in the region.

New as well as seasoned entrepreneurs pitch their businesses at their exhibitor booths to avail the enormous reach and connections that the CannaCon conferences offer. The event organizers ensure exhibitors have all the requisite resources at their disposal for setting up their booths.

To learn more, please visit https://ibn.fm/1NRZ5